These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9340805)

  • 1. Control of hemorrhage and elimination of immune inhibitors in a female patient with a severe form of von Willebrand's disease.
    Marisavljević D; Elezović I; Miljić P; Radulović M; Stajić M
    Srp Arh Celok Lek; 1997; 125(9-10):311-6. PubMed ID: 9340805
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor.
    Grossmann RE; Geisen U; Schwender S; Keller F
    Thromb Haemost; 2000 Apr; 83(4):633-4. PubMed ID: 10780333
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of von Willebrand's disease.
    Logan LJ
    Prog Clin Biol Res; 1990; 324():279-90. PubMed ID: 2106690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor (author's transl)].
    Fukui H; Okuda T; Takase T; Mikami S; Yoshioka A; Fujimura Y; Yoshioka K
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):897-907. PubMed ID: 310619
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of a hemorrhagic syndrome in severe von Willebrand disease in the presence of circulating anti-von-Willebrand-factor antibody].
    Monteagudo J; López Guillermo A; Castillo R
    Med Clin (Barc); 1988 May; 91(1):28-30. PubMed ID: 3139944
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pregnancy and delivery in a patient with Willebrand's disease. Apropos of a case].
    Cherkaoui S; Laaloui A; Faiz S; Benchemsi N
    Transfus Clin Biol; 2007 Nov; 14(5):474-80. PubMed ID: 18295527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Willebrand's disease and pregnancy. Fifteen cases].
    Depret-Mosser S; Marey A; Parquet-Gernez A; Theeten G; Goudemand J; Codaccioni X; Vinatier D; Monnier JC
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(4):405-10. PubMed ID: 8815140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2B von Willebrand's disease and angiodysplasia.
    Hertzberg MS; Facey DA; Favaloro EJ; Koutts J
    Thromb Haemost; 1999 Nov; 82(5):1557-8. PubMed ID: 10595657
    [No Abstract]   [Full Text] [Related]  

  • 11. von Willebrand's disease in Sweden.
    Silwer J
    Acta Paediatr Scand Suppl; 1973; 238():1-159. PubMed ID: 4550005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired von Willebrand's syndrome: a single institution experience.
    Kumar S; Pruthi RK; Nichols WL
    Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of severe hemorrhage by using thrombocyte suspension with cryoprecipitate in type III Willebrand disease].
    Boda Z; Pfliegler G; Hársfalvi J; Rák K
    Orv Hetil; 1991 Nov; 132(45):2499-502. PubMed ID: 1945395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhaging at menarche: a case report.
    Ward CL
    J Fam Pract; 1992 Mar; 34(3):351-4. PubMed ID: 1541960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of transfusion hemostatic therapy in patients with Willebrand's disease during surgical intervention].
    Kudriavtseva LM; Pliushch OP; Matveeva TI
    Anesteziol Reanimatol; 1993; (2):62-3. PubMed ID: 7943887
    [No Abstract]   [Full Text] [Related]  

  • 17. Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval.
    Moayeri SE; Coutre SE; Ramirez EJ; Westphal LM
    Am J Obstet Gynecol; 2007 Apr; 196(4):e10-1. PubMed ID: 17403383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathogenesis of acquired von Willebrand's disease in a patient with asymptomatic monoclonal gammopathy; malignant lymphoma developing 30 months after onset of bruising].
    Takai Y; Hayasi H; Tsurumi N; Tsuda T; Fujlta T; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1987 Jan; 28(1):53-64. PubMed ID: 3494863
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
    Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M
    Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.